| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.41B | 30.16B | 29.19B | 27.88B | 28.17B | 28.37B |
| Gross Profit | 2.29B | 2.36B | 2.19B | 2.03B | 2.13B | 2.22B |
| EBITDA | 2.78B | 2.93B | 2.70B | 2.53B | 2.58B | 2.71B |
| Net Income | 1.70B | 1.66B | 1.50B | 1.37B | 1.35B | 1.44B |
Balance Sheet | ||||||
| Total Assets | 50.54B | 50.34B | 48.59B | 47.53B | 45.83B | 43.25B |
| Cash, Cash Equivalents and Short-Term Investments | 7.21B | 6.07B | 6.35B | 6.56B | 8.33B | 7.67B |
| Total Debt | 17.21B | 14.75B | 15.18B | 16.19B | 16.29B | 14.38B |
| Total Liabilities | 23.61B | 21.22B | 21.94B | 22.34B | 22.59B | 21.07B |
| Stockholders Equity | 26.93B | 29.12B | 26.65B | 25.20B | 23.24B | 22.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 300.79M | 1.03B | -1.25B | -646.39M | 1.93B |
| Operating Cash Flow | 0.00 | 2.25B | 3.24B | 1.81B | 2.65B | 2.83B |
| Investing Cash Flow | 0.00 | -1.59B | -2.01B | -3.08B | -3.36B | -816.68M |
| Financing Cash Flow | 0.00 | -936.11M | -1.44B | -508.71M | 1.37B | -783.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥14.29B | 9.45 | ― | 3.85% | 8.49% | 32.73% | |
65 Neutral | ¥13.46B | 9.42 | ― | 3.04% | 3.34% | 11.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥307.18B | 26.94 | ― | 1.28% | 6.67% | 10.43% | |
60 Neutral | ¥943.35B | 15.06 | 9.97% | 3.54% | 11.19% | 5.65% | |
59 Neutral | ¥297.34B | 17.48 | ― | 2.94% | 1.47% | -10.54% | |
56 Neutral | ¥1.19T | 47.02 | ― | 2.99% | -0.90% | -81.16% |